Citigroup
LEGN icon

Citigroup’s Legend Biotech LEGN Stock Holding History

Citigroup’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.51M Buy
75,885
+19,638
+35% +$419K ﹤0.01% 3028
2026
Q2 		$1.62M Sell
56,247
-23,702
-30% -$639K ﹤0.01% 3087
2026
Q1 		$1.45M Buy
79,949
+4,952
+7% +$94.4K ﹤0.01% 2873
2025
Q4 		$1.63M Buy
74,997
+27,521
+58% +$788K ﹤0.01% 2793
2025
Q3 		$1.55M Buy
47,476
+5,130
+12% +$189K ﹤0.01% 2884
2025
Q2 		$1.5M Buy
42,346
+4,183
+11% +$136K ﹤0.01% 2900
2025
Q1 		$1.29M Sell
38,163
-7,385
-16% -$265K ﹤0.01% 3061
2024
Q4 		$1.48M Buy
45,548
+3,550
+8% +$147K ﹤0.01% 3045
2024
Q3 		$2.05M Sell
41,998
-1,482
-3% -$78.9K ﹤0.01% 2645
2024
Q2 		$1.93M Buy
43,480
+3,776
+10% +$174K ﹤0.01% 2381
2024
Q1 		$2.23M Sell
39,704
-30,795
-44% -$1.86M ﹤0.01% 2358
2023
Q4 		$4.24M Sell
70,499
-8,895
-11% -$564K ﹤0.01% 1698
2023
Q3 		$5.33M Buy
79,394
+4,427
+6% +$307K ﹤0.01% 1395
2023
Q2 		$5.17M Sell
74,967
-8,103
-10% -$529K ﹤0.01% 1469
2023
Q1 		$4.01M Buy
83,070
+7,265
+10% +$355K ﹤0.01% 1617
2022
Q4 		$3.78M Buy
75,805
+5,491
+8% +$266K ﹤0.01% 1625
2022
Q3 		$2.87M Sell
70,314
-44,082
-39% -$2.07M ﹤0.01% 1896
2022
Q2 		$6.29M Buy
114,396
+53,094
+87% +$2.24M ﹤0.01% 1398
2022
Q1 		$2.23M Buy
61,302
+11,188
+22% +$442K ﹤0.01% 2281
2021
Q4 		$2.34M Buy
50,114
+34,543
+222% +$1.75M ﹤0.01% 2488
2021
Q3 		$788K Buy
15,571
+7,828
+101% +$326K ﹤0.01% 3271
2021
Q2 		$318K Buy
7,743
+7,286
+1,594% +$248K ﹤0.01% 3979
2021
Q1 		$13K Sell
457
-183
-29% -$4.99K ﹤0.01% 5486
2020
Q4 		$18K Buy
+640
New +$18.4K ﹤0.01% 6716

Other funds holding LEGN

Matthews International Capital Management
Matthews International Capital Management San Francisco, California $241M AUM 42.66% 1-Year Est. Return
Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
Granite Investment Partners
Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
iA Global Asset Management
iA Global Asset Management Quebec, Quebec, Canada $8.54B AUM 39.73% 1-Year Est. Return
Raiffeisen Bank International
Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
NLB Skladi upravljanje premozenja
NLB Skladi upravljanje premozenja Ljubljana $2.71B AUM 53.8% 1-Year Est. Return

Citigroup's LEGN Position: Q3 2026 in Review

Citigroup increased its Legend Biotech (LEGN) stake by 35% in Q3 2026, buying an estimated $419K and bringing the position to 75,885 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #3028.

Citigroup first reported a position in LEGN in Q4 2020 and has held it in 24 quarters since. The position peaked at $6.29M in Q2 2022. 52 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

  • Citigroup held 75,885 shares of Legend Biotech worth $1.51M as of Q3 2026.
  • Citigroup bought 19,638 Legend Biotech shares in Q3 2026, an estimated $419K.
  • Legend Biotech made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #3028 holding.
  • Citigroup first reported a position in Legend Biotech in Q4 2020 and has held it in 24 quarters since.
  • Citigroup's Legend Biotech position peaked at $6.29M in Q2 2022.
  • 52 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.